THE U.S. VITAL SIGNS MONITORING DEVICES MARKET WAS VALUED AT USD 7.21 BILLION IN 2022 AND IS EXPECTED TO REACH USD 11.21 BILLION BY 2028, GROWING AT A CAGR OF 7.62% DURING THE FORECAST PERIOD.

The U.S. Vital Signs Monitoring Devices Market Size, Share, & Trends Analysis Report By

  • Product: Standalone Vital Sign Monitoring Devices (Heart Rate/Cardiac Monitors, Pulse Oximeters, Blood Pressure Monitors, and Body Temperature Monitors) and Integrated Vital Sign Monitoring Devices
  • Patient Group: Geriatric Patient Group, Adult Patient Group, and Pediatric Patient Group
  • Application: Chronic Care and Acute Care
  • End-user: Hospitals, Homecare Settings & Individuals, Ambulatory Care Settings, and Others

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

260 Pages

icon-table

55 Tables

icon-chart

97 Charts

icon-region

1 Regions

icon-country

1 Countries

icon-company

35 Companies

icon-market

4 Market Segment

U.S. VITAL SIGNS MONITORING DEVICES MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (2028) USD 11.21 Billion
MARKET SIZE (2022) USD 7.21 Billion
CAGR (2022-2028) 7.62%
Base Year 2022
Forecast Year 2023-2028
Market Segments Product, Patient Group, Application, and End-user
Geographic Analysis United States
KEY VENDORS A&D Company, Baxter, CONTEC MEDICAL SYSTEMS, GE Healthcare, ICU Medical, Koninklijke Philips, Masimo, Medtronic, NIHON KOHDEN, Nonin, OMRON, and OSI Systems

The U.S. vital signs monitoring devices market size was valued at USD 7.21 billion in 2022 and is expected to reach USD 11.21 billion by 2028, growing at a CAGR of 7.62%. Detecting or monitoring medical problems with the help of vital signs monitoring devices in a medical setting, at home, or the site of a medical emergency is helpful in the early diagnosis of various medical conditions among patients. Vital signs provide critical information about a patient’s health to identify acute medical problems, indicate chronic disease state, and understand how the body copes with physiological stress.

Vital signs are important in detecting or monitoring medical problems/ailments. The four major vital signs healthcare professional monitors are heart rate/cardiac, body temperature, pulse rate, and blood pressure. These signs can easily be monitored in medical settings, at home, or in other places. Vital signs provide critical information about a patient’s health to identify acute medical problems, indicate chronic disease state, and understand how the body copes with physiological stress. The normal ranges of the four major vital signs (body temperature, blood pressure, pulse, and breathing rate) vary with age, gender, weight, as well as the overall health of the person.

On the other hand, the COVID-19 pandemic has brought significant challenges to the entire healthcare industry and impacted the growth of the U.S. vital signs monitoring devices market. This has accelerated the adoption of vital signs monitoring devices in the patient population and end-user. Similarly, most people are opting for home precautions with the help of temperature monitoring devices to measure their body temperature amid the pandemic. Also, amid COVID-19, vital signs monitoring devices, such as standalone or wearable devices, have gained significant traction in clinical trial studies over patients and support providers with systematic, real-time information.

Vital signs patient monitors are used to monitor patients' vital signs in emergency care settings and for continuous management of chronic diseases. There is rising demand for various vital signs monitoring devices to treat this increasing patient population. As the demand for these devices has increased, vendors are constantly focusing on increasing their production capacity to meet the increasing demand and provide quality care to patients in the U.S. vital signs monitoring devices market. Further, patients’ vital signs monitors are the most required products, along with portable ventilators and medical consumables for non-invasive and invasive ventilation to treat a broad range of respiratory conditions.

Also, the increased awareness of telemedicine is anticipated to drive the U.S. vital signs monitoring devices market during the forecast period. Further, the increase in demand for technologically advanced products due to benefits over traditional ones is anticipated to fuel the growth of the US vital signs monitoring devices market. Companies are investing in the development of advanced products to improve treatment.

MARKET TRENDS & DRIVERS

Increasing Need for wireless Patient Monitoring at Home
Over the past few years, home patient monitoring has become a standard of care among adult patients who require a long-term alternative to hospital-based care. The trend toward using a wireless patient monitoring system to monitor vital signs continues to grow. Among the many benefits being brought to the healthcare service by wireless patient monitoring is the facility to escalate home care for both chronic and acute conditions. Various pandemic-related factors have created an opportunity to integrate care at home. The emergence of new technologies and capabilities makes taking care of one at home possible.

Advances in Remote Patient Monitoring (RPM)
The COVID-19 pandemic has accelerated this trend by highlighting the need and value of RPM. RPM has caught the attention of many medical professionals. More recently, IoT-enabled monitoring devices have added even more functionality to RPM. Physicians using IoT-enabled RPM systems benefit more from their patients. By combining AI with the Internet of Things (IoT) and RPM, healthcare organizations and practitioners can better serve their patients and provide opportunities for improved healthcare outcomes.

Upcoming Technologies in Vital Sign Monitoring
IoT technologies have penetrated several healthcare fields, from follow-up to rehabilitation therapies, personal monitoring of daily activities, reminders of medical appointments and medication intakes, and remote monitoring of patient's vital signs. Recently, advances in sensors and mobile devices have led to the development of wearable vital signs monitoring devices that connect with smartphones. This help to analyze the data obtained from people who use them to monitor their health, suggest improvements, and even predict hidden diseases through intelligent algorithms applied to the data sensed from devices such as Bracelets and smartwatches. Through medical IoT technology, physicians or caregivers responsible for patients' health can remotely know, in real-time, the physical condition of people.

Rise of Virtual Clinical Trials
In remote and decentralized trials, collecting this data directly from patients at home is critical. As known during the pandemic, the monitoring activity at clinical sites has been strongly impacted and revolutionized. Virtual clinical trials (VCT) rely on technologies such as apps, web-based platforms, wearable devices, and remote monitoring. Decentralized clinical trials (DCTs) are being increasingly implemented and have gained more attention due to the COVID-19 pandemic.

Rising Prevalence of Chronic Disorders Augmenting the Need for Continuous Monitoring
Chronic diseases have significant health and economic costs in the U.S. Around 90% of the nation’s USD 4.1 trillion annual healthcare expenditures are for people with chronic and mental health conditions. Seventy-one percent of U.S. healthcare spending goes to treating people with multiple chronic conditions. As the American workforce grows and ages, so do its health needs. Addressing employee health is no longer an option; it’s a priority. As healthcare costs continue to rise, organizations are taking bigger steps to ensure the sustainability of their business and the growing need to manage both people and profit effectively.

Chronic disease management and home health initiatives can reduce care costs and promote better patient outcomes. A crucial tool in these programs—remote patient monitoring is helping one academic medical center succeed in these efforts.

Growing Preference for Integrated Vital Signs Monitors
In recent years, it has become much more common to find continuous, low-acuity monitoring at the bedside to proactively manage patients at risk of adverse events in which spot-checks may miss important markers. It is observed that there is a high requirement for integrated vital signs monitors outside hospitals. For instance, in the ambulance, the multi-parameter monitors need to continuously monitor the vital sign of the patient during emergency transport. The increased demand for integrated vital signs monitors with remote monitoring platforms encourages vendors to develop and commercialize such devices catering to end-user requirements.

Manufacturers’ Increasing Focus on Developing Software & Apps for Vital Signs Monitoring
Manufacturers are focusing on developing software solutions as there is an increasing focus on automated documentation—that is, the electronic transfer of data from the vital signs monitor to the hospital’s electronic medical record (EMR) system. This can reduce some of the potential for errors resulting from manual documentation of patient data. Some vital signs monitor vendors to provide specialized connectivity solutions/software that accomplish this. At the same time, some of these solutions are specific to the vendor’s vital signs monitors and may be compatible with vital signs monitors from multiple vendors.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT
The U.S. vital signs monitoring devices market by product is segmented into standalone and integrated vital signs monitoring devices. The standalone segment accounted for 63.52% in 2022, followed by the integrated segment. Standalone vital signs monitoring devices include blood pressure, body temperature, pulse oximeters, and heart rate/cardiac monitors. These devices measure blood pressure, temperature, saturated oxygen levels, and pulse rates. Standalone vital sign monitors are easy to transfer from one location to another. They are typically lightweight and compact, making it easy to keep tabs on a given patient’s vital signs wherever they are. The standalone segment further comprises heart rate/cardiac monitors, pulse oximeters, blood pressure monitors, and body temperature monitors. Under which the heart rate/cardiac monitors segment accounted for the major market share of 61.93%.

INSIGHTS BY PATIENT GROUP
The geriatric patient group segment accounted for 53.23% of the U.S. vital signs monitoring devices market share and dominated the patient group segment. With the rising elderly population, there is a surge in various chronic disease prevalence rates. Also, it has been reported that the major chronic illnesses that burden the country's aging population include hypertension, high cholesterol, arthritis, diabetes, heart disease, cancer, and dementia. Vital signs of this aging population need to be monitored on time to provide them with high-quality care and avoid fatal conditions, enhancing market growth.

The pediatric patient group in the U.S. vital signs monitoring devices market is growing quickly and is likely to grow at a CAGR of 8.10% during the projected period. Infectious diseases have been significantly reduced, and child survival rates for cancer, congenital heart disease, leukemia, etc., have greatly improved. However, over the past few years, there has been a steady increase in chronic health conditions and disabilities in children and adolescents, primarily in four common disorders, including asthma, obesity, psychiatric disorders, and neurodevelopmental disorders. This has increased the demand for vital signs monitoring devices to support these pediatric patient populations and provide them with high-quality care.

INSIGHTS BY APPLICATION
The U.S. vital signs monitoring devices market is segmented into chronic care and acute care by application, and in 2022, the chronic care segment dominated the segment accounting for 73.62%. Chronic diseases are physical or mental illnesses such as hypertension, diabetes, cardiovascular disease, obesity, and stroke. These diseases represent the most health risks and are responsible for over two-thirds of deaths in the U.S. There is an increasing need to develop vital signs monitoring solutions to manage chronic diseases. Such systems or solutions are used for continuous monitoring, diagnosis, prognosis, and treatment. Hence, they help to reduce healthcare costs and allow patients to go about smoothly with their daily lives while their vital signs are fully monitored.

INSIGHTS BY END-USER

The U.S. vital signs monitoring devices market is segmented into hospitals, ambulatory care settings, home care settings & individuals, and others by end-user. The hospital's segment accounted for the largest share of the end-user segment in 2022. Vital signs are essential to monitoring adult or child patients’ progress during hospitalization, as they allow for prompt detection of delayed recovery or adverse events. Vital signs are measured to obtain the basic parameters of a patient's health status. The most common intervention in the hospital is the measurement of vital signs, which traditionally consist of blood pressure, temperature, pulse rate, and respiratory rate.

The ambulatory care setting segment in the U.S. vital signs monitoring devices market is growing at a CAGR of 8.57% during the forecast period. Ambulatory care centers are cost-effective and offer quality care with a minimal indirect cost of treatment. The requirement for vital signs monitors, especially integrated ones, is relatively less in ASCs than in hospitals as most procedures are daycare ones, and the patient stay is less. As bulky and fixed integrated patient monitors are relatively less, ambulatory care settings prefer portable and compact vital signs and standalone devices for monitoring patients' vital signs.

VENDOR LANDSCAPE

The U.S. vital signs monitoring devices market is highly competitive and consists of several major players. The industry is fragmented, with various global, local, and regional manufacturers. Owing to continuous technological advancements and product innovations, mid-sized and emerging vendors are increasing their market presence by introducing new products at competitive prices. Also, the market potential drives several players to expand their share through acquisitions. Many U.S. vital signs monitoring devices market vendors are adopting various strategies to increase their presence in many major markets.

A&D Company, Baxter, CONTEC MEDICAL SYSTEMS, GE Healthcare, ICU Medical, Koninklijke Philips, Masimo, Medtronic, NIHON KOHDEN, Nonin, OMRON, and OSI Systems are some of the major vendors offering a wide range of both standalone and integrated vital signs monitors in the U.S. vital signs monitoring devices market. However, many local vendors are providing products with similar specifications at lower prices, which has resulted in a price war among vendors. Major vendors continuously compete for the leading position in the market, with occasional competition from other local vendors.

Recent Vendor's Activities in the U.S. vital signs monitoring devices market

  • In January 2022, ICU Medical acquired Smiths Medical. The addition of vital care products expanded the business range of ICU Medical with a robust reach.
  • In December 2021, Baxter acquired Hillrom, a medical technology leader. Before that, in January 2021, Hillrom acquired Bardy Diagnostics, an innovator in digital health and a leading provider of ambulatory cardiac monitoring technologies.
  • In February 2021, Koninklijke Philips completed the acquisition of BioTelemetry. The acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio. The combination results in the business expansion of patient care management solutions for the hospital and homes.

Frequently Asked Questions

How big is the U.S. vital signs monitoring devices market?

The U.S. vital signs monitoring devices market size was valued at USD 7.21 billion in 2022 and is expected to reach USD 11.21 billion by 2028.

What is the growth rate of the U.S. vital signs monitoring devices market?

The U.S. vital signs monitoring devices market share is growing at a CAGR of 7.62% from 2022-2028.

What are the growing trends in the U.S. vital signs monitoring devices market?

Increasing demand for wireless patient monitoring at home, the rise of virtual clinical trials, advances in remote patient monitoring technology, and upcoming technologies in vital signs monitoring are trends in the U.S. vital signs monitoring devices market.

Which product segment dominates the U.S. vital signs monitoring devices market?

Standalone vital signs monitoring devices dominated the US vital signs monitoring devices market, accounting for a 63.52% share in 2022.

Who are the key players in the U.S. vital signs monitoring devices market?

A&D Company, Baxter, CONTEC MEDICAL SYSTEMS, GE Healthcare, ICU Medical, Koninklijke Philips, Masimo, Medtronic, NIHON KOHDEN, Nonin, OMRON, and OSI Systems are the key players in U.S. vital signs monitoring devices market.

Download Free Sample

The U.S. vital signs monitoring devices market size is expected to grow at a CAGR of approximately 7.62% from 2022 to 2028.

The following factors are likely to contribute to the growth of the U.S. vital signs monitoring devices market during the forecast period:

  • Increasing Prevalence of Chronic Disorders augmenting Continuous Monitoring Demand
  • The Enhancements in Vital Signs Monitors
  • Increased Preference for Integrated Vital Signs Monitors
  • Increasing Focus on Developing Software & Apps for Vital Signs Monitoring by Manufacturers

Base Year: 2022

Forecast Year: 2023-2028

The report considers the present scenario of the U.S. vital signs monitoring devices market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.

Key Company Profiles

  • A&D Company
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Baxter
  • CONTEC MEDICAL SYSTEMS
  • GE Healthcare
  • ICU Medical
  • Koninklijke Philips
  • Masimo
  • Medtronic
  • NIHON KOHDEN
  • Nonin
  • OMRON
  • OSI Systems

Other Prominent Vendors

  • 100-Plus
    • Business Overview
    • Product Offerings
  • Advanced Instrumentations
  • American Diagnostic
  • Bittium
  • Cardinal Health
  • Compass Health Brands
  • Drägerwerk AG & Co.
  • EDAN Instruments
  • FUKUDA DENSHI
  • Halma
  • Infinium Medical
  • Mennen Medical
  • Microlife
  • NURECA
  • Oxitone
  • Qardio
  • Rossmax International
  • Solaris Medical Technology
  • Sunset Healthcare Solutions
  • Viatom Technology
  • VitalConnect
  • VivaLNK
  • VYAIRE MEDICAL

Segmentation by Product

  • Standalone Vital Sign Monitoring Devices
    • Heart Rate/Cardiac Monitors
    • Pulse Oximeters
    • Blood Pressure Monitors
    • Body Temperature Monitors
  • Integrated Vital Sign Monitoring Devices

Segmentation by Patient Group

  • Geriatric Patient Group
  • Adult Patient Group
  • Pediatric Patient Group

Segmentation by Application

  • Chronic Care
  • Acute Care

Segmentation by End-user

  • Hospitals
  • Homecare Settings & Individuals
  • Ambulatory Care Settings
  • Others

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCT

4.3.2 MARKET SEGMENTATION BY PATIENT GROUP

4.3.3 MARKET SEGMENTATION BY APPLICATION

4.3.4 MARKET SEGMENTATION BY END-USER

4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

7.1 MARKET OVERVIEW

8 INTRODUCTION

8.1 OVERVIEW

8.1.1 COVID-19 IMPACT

8.1.2 REIMBURSEMENT SCENARIO FOR VITAL SIGNS MONITORS

8.1.3 WEARABLE TECHNOLOGY IN VITAL SIGNS MONITORING DEVICES

9 MARKET OPPORTUNITIES & TRENDS

9.1 INCREASING DEMAND FOR WIRELESS PATIENT MONITORING AT HOME

9.2 RISE OF VIRTUAL CLINICAL TRIALS

9.3 ADVANCES IN REMOTE PATIENT MONITORING TECHNOLOGY

9.4 UPCOMING TECHNOLOGIES IN VITAL SIGNS MONITORING

10 MARKET GROWTH ENABLERS

10.1 INCREASING PREVALENCE OF CHRONIC DISORDERS AUGMENTING CONTINUOUS MONITORING DEMAND

10.2 ENCHANCEMENTS IN VITAL SIGNS MONITORS

10.3 INCREASED PREFERENCE FOR INTEGRATED VITAL SIGNS MONITORS

10.4 INCREASING FOCUS ON DEVELOPING SOFTWARE & APPS FOR VITAL SIGNS MONITORING BY MANUFACTURERS

11 MARKET RESTRAINTS

11.1 CYBERSECURITY & RELATED LIMITATIONS WITH VITAL SIGNS MONITORS

11.2 FALSE ALARMS & ALARM FATIGUE ASSOCIATED WITH VITAL SIGNS MONITORS

11.3 INTENSE COMPETITION COUPLED WITH PRICING PRESSURES

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 PRODUCT SEGMENTATION INSIGHTS

12.2.2 PATIENT GROUP SEGMENTATION INSIGHTS

12.2.3 APPLICATION SEGMENTATION INSIGHTS

12.2.4 END-USER SEGMENTATION INSIGHTS

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 THREAT OF RIVALRY

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 STANDALONE VITAL SIGNS MONITORS

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 HEART RATE/CARDIAC MONITORS

13.3.4 PULSE OXIMETERS: MARKET SIZE AND FORECAST

13.3.5 BLOOD PRESSURE MONITORS: MARKET SIZE AND FORECAST

13.3.6 BODY TEMPERATURE MONITORS

13.4 INTEGRATED VITAL SIGNS MONITORS

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

14 PATIENT GROUP

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 GERIATRIC PATIENT GROUP

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.4 ADULT PATIENT GROUP

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.5 PEDIATRIC PATIENT GROUP

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

15 APPLICATION

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 CHRONIC CARE

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.4 ACUTE CARE

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

16 END-USER

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.2.1 KEY BUYING CRITERIA AND BUYING BEHAVIOR PATTERNS

16.3 HOSPITALS

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.4 AMBULATORY CARE SETTINGS

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.5 HOMECARE SETTINGS & INDIVIDUALS

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.6 OTHERS

16.6.1 MARKET OVERVIEW

16.6.2 MARKET SIZE & FORECAST

17 COMPETITIVE LANDSCAPE

17.1 COMPETITION OVERVIEW

17.1.1 VENDORS RECENT ACTIVITIES: M&AS AND PRODUCT LAUNCHES

17.2 MARKET SHARE ANALYSIS

17.2.1 A&D COMPANY

17.2.2 BAXTER

17.2.3 CONTEC MEDICAL SYSTEMS

17.2.4 GE HEALTHCARE

17.2.5 ICU MEDICAL

17.2.6 KONINKLIJKE PHILIPS

17.2.7 MASIMO

17.2.8 MEDTRONIC

17.2.9 NIHON KOHDEN

17.2.10 NONIN

17.2.11 OMRON

17.2.12 OSI SYSTEMS

18 KEY COMPANY PROFILES

18.1 A&D COMPANY

18.1.1 BUSINESS OVERVIEW

18.1.2 PRODUCT OFFERINGS

18.1.3 KEY STRATEGIES

18.1.4 KEY STRENGTHS

18.1.5 KEY OPPORTUNITIES

18.2 BAXTER

18.2.1 BUSINESS OVERVIEW

18.2.2 PRODUCT OFFERINGS

18.2.3 KEY STRATEGIES

18.2.4 KEY STRENGTHS

18.2.5 KEY OPPORTUNITIES

18.3 CONTEC MEDICAL SYSTEMS

18.3.1 BUSINESS OVERVIEW

18.3.2 PRODUCT OFFERINGS

18.3.3 KEY STRATEGIES

18.3.4 KEY STRENGTHS

18.3.5 KEY OPPORTUNITIES

18.4 GE HEALTHCARE

18.4.1 BUSINESS OVERVIEW

18.4.2 PRODUCT OFFERINGS

18.4.3 KEY STRATEGIES

18.4.4 KEY STRENGTHS

18.4.5 KEY OPPORTUNITIES

18.5 ICU MEDICAL

18.5.1 BUSINESS OVERVIEW

18.5.2 PRODUCT OFFERINGS

18.5.3 KEY STRATEGIES

18.5.4 KEY STRENGTHS

18.5.5 KEY OPPORTUNITIES

18.6 KONINKLIJKE PHILIPS

18.6.1 BUSINESS OVERVIEW

18.6.2 PRODUCT OFFERINGS

18.6.3 KEY STRATEGIES

18.6.4 KEY STRENGTHS

18.6.5 KEY OPPORTUNITIES

18.7 MASIMO

18.7.1 BUSINESS OVERVIEW

18.7.2 PRODUCT OFFERINGS

18.7.3 KEY STRATEGIES

18.7.4 KEY STRENGTHS

18.7.5 KEY OPPORTUNITIES

18.8 MEDTRONIC

18.8.1 BUSINESS OVERVIEW

18.8.2 PRODUCT OFFERINGS

18.8.3 KEY STRATEGIES

18.8.4 KEY STRENGTHS

18.8.5 KEY OPPORTUNITIES

18.9 NIHON KOHDEN

18.9.1 BUSINESS OVERVIEW

18.9.2 PRODUCT OFFERINGS

18.9.3 KEY STRATEGIES

18.9.4 KEY STRENGTHS

18.9.5 KEY OPPORTUNITIES

18.10 NONIN

18.10.1 BUSINESS OVERVIEW

18.10.2 PRODUCT OFFERINGS

18.10.3 KEY STRATEGIES

18.10.4 KEY STRENGTHS

18.10.5 KEY OPPORTUNITIES

18.11 OMRON

18.11.1 BUSINESS OVERVIEW

18.11.2 PRODUCT OFFERINGS

18.11.3 KEY STRATEGIES

18.11.4 KEY STRENGTHS

18.11.5 KEY OPPORTUNITIES

18.12 OSI SYSTEMS

18.12.1 BUSINESS OVERVIEW

18.12.2 PRODUCT OFFERINGS

18.12.3 KEY STRATEGIES

18.12.4 KEY STRENGTHS

18.12.5 KEY OPPORTUNITIES

19 OTHER PROMINENT VENDORS

19.1 100-PLUS

19.1.1 BUSINESS OVERVIEW

19.1.2 PRODUCT OFFERINGS

19.2 ADVANCED INSTRUMENTATIONS

19.2.1 BUSINESS OVERVIEW

19.2.2 PRODUCT OFFERINGS

19.3 AMERICAN DIAGNOSTIC

19.3.1 BUSINESS OVERVIEW

19.3.2 PRODUCT OFFERINGS

19.4 BITTIUM

19.4.1 BUSINESS OVERVIEW

19.4.2 PRODUCT OFFERINGS

19.5 CARDINAL HEALTH

19.5.1 BUSINESS OVERVIEW

19.5.2 PRODUCT OFFERINGS

19.6 COMPASS HEALTH BRANDS

19.6.1 BUSINESS OVERVIEW

19.6.2 PRODUCT OFFERINGS

19.7 DRÄGERWERK AG & CO.

19.7.1 BUSINESS OVERVIEW

19.7.2 PRODUCT OFFERINGS

19.8 EDAN INSTRUMENTS

19.8.1 BUSINESS OVERVIEW

19.8.2 PRODUCT OFFERINGS

19.9 FUKUDA DENSHI

19.9.1 BUSINESS OVERVIEW

19.9.2 PRODUCT OFFERINGS

19.1 HALMA

19.10.1 BUSINESS OVERVIEW

19.10.2 PRODUCT OFFERINGS

19.11 INFINIUM MEDICAL

19.11.1 BUSINESS OVERVIEW

19.11.2 PRODUCT OFFERINGS

19.12 MENNEN MEDICAL

19.12.1 BUSINESS OVERVIEW

19.12.2 PRODUCT OFFERINGS

19.13 MICROLIFE

19.13.1 BUSINESS OVERVIEW

19.13.2 PRODUCT OFFERINGS

19.14 NURECA

19.14.1 BUSINESS OVERVIEW

19.14.2 PRODUCT OFFERINGS

19.15 OXITONE

19.15.1 BUSINESS OVERVIEW

19.15.2 PRODUCT OFFERINGS

19.16 QARDIO

19.16.1 BUSINESS OVERVIEW

19.16.2 PRODUCT OFFERING

19.17 ROSSMAX INTERNATIONAL

19.17.1 BUSINESS OVERVIEW

19.17.2 PRODUCT OFFERINGS

19.18 SOLARIS MEDICAL TECHNOLOGY

19.18.1 BUSINESS OVERVIEW

19.18.2 PRODUCT OFFERINGS

19.19 SUNSET HEALTHCARE SOLUTIONS

19.19.1 BUSINESS OVERVIEW

19.19.2 PRODUCT OFFERINGS

19.20 VIATOM TECHNOLOGY

19.20.1 BUSINESS OVERVIEW

19.20.2 PRODUCT OFFERINGS

19.21 VITALCONNECT

19.21.1 BUSINESS OVERVIEW

19.21.2 PRODUCT OFFERINGS

19.22 VIVALNK

19.22.1 BUSINESS OVERVIEW

19.22.2 PRODUCT OFFERINGS

19.23 VYAIRE MEDICAL

19.23.1 BUSINESS OVERVIEW

19.23.2 PRODUCT OFFERINGS

20 REPORT SUMMARY

20.1 KEY TAKEAWAYS

20.2 STRATEGIC RECOMMENDATIONS

21 QUANTITATIVE SUMMARY

21.1 MARKET BY PRODUCT

21.2 MARKET BY PATIENT GROUP

21.3 MARKET BY APPLICATION

21.4 MARKET BY END-USER

22 APPENDIX

22.1 ABBREVIATIONS

EXHIBIT 1 SEGMENTATION OF THE US VITAL SIGNS MONITORING DEVICES MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022

EXHIBIT 3 FEATURES OF VITAL SIGN MONITORING DEVICES

EXHIBIT 4 CONVERGENCE OF TECHNOLOGIES LEADING TO INDUSTRIAL REVOLUTION

EXHIBIT 5 ADVANTAGES OF USING REMOTE BIOSENSORS IN CLINICAL RESEARCH

EXHIBIT 6 IMPACT OF INCREASING DEMAND FOR WIRELESS PATIENT MONITORING AT HOME

EXHIBIT 7 IMPACT OF RISE OF VIRTUAL CLINICAL TRIALS

EXHIBIT 8 PATIENT MONITORING EXAMPLES: AN OVERVIEW OF WEARABLE AND DEVICE INTEGRATION IN DCTS

EXHIBIT 9 IMPACT OF ADVANCES IN REMOTE PATIENT MONITORING TECHNOLOGY

EXHIBIT 10 IMPACT OF UPCOMING TECHNOLOGIES IN VITAL SIGNS MONITORING

EXHIBIT 11 IMPACT OF INCREASING PREVALENCE OF CHRONIC DISORDERS AUGMENTING CONTINUOUS MONITORING DEMAND

EXHIBIT 12 PREVALENCE DATA OF CHRONIC DISEASES IN THE US

EXHIBIT 13 IMPACT OF ENHANCEMENTS IN VITAL SIGNS MONITORS

EXHIBIT 14 IMPACT OF INCREASED PREFERENCE FOR INTEGRATED VITAL SIGNS MONITORS

EXHIBIT 15 IMPACT OF INCREASING FOCUS ON DEVELOPING SOFTWARE & APPS FOR VITAL SIGNS MONITORING BY MANUFACTURERS

EXHIBIT 16 IMPACT OF CYBERSECURITY & RELATED LIMITATIONS WITH VITAL SIGNS MONITORS

EXHIBIT 17 IMPACT OF FALSE ALARMS & ALARM FATIGUE ASSOCIATED WITH VITAL SIGNS MONITORS

EXHIBIT 18 CLASSIFICATION OF TRIGGERED ALARMS & THEIR SHARE IN HEALTHCARE SETTINGS

EXHIBIT 19 IMPACT OF INTENSE COMPETITION COUPLED WITH PRICING PRESSURES

EXHIBIT 20 US VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 21 US VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: MARKET SHARE 2022 & 2028 (%)

EXHIBIT 22 US VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: MARKET SHARE 2022 & 2028 (%)

EXHIBIT 23 US VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: MARKET SHARE 2022 & 2028 (%)

EXHIBIT 24 US VITAL SIGNS MONITORING DEVICES MARKET BY END-USER: MARKET SHARE 2022 & 2028 (%)

EXHIBIT 25 FIVE FORCES ANALYSIS 2022

EXHIBIT 26 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028

EXHIBIT 27 US VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 28 US VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: ABSOLUTE GROWTH (%)

EXHIBIT 29 REASONS TO CHOOSE STANDALONE VITAL SIGNS MONITORING DEVICES

EXHIBIT 30 US STANDALONE VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 31 US STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 32 US VITAL SIGNS MONITORING DEVICES BY HEART RATE/CARDIAC MONITORING DEVICES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 33 US VITAL SIGNS MONITORING DEVICES BY HEART RATE/CARDIAC MONITORING DEVICES 2022–2028 ($ BILLION)

EXHIBIT 34 US VITAL SIGNS MONITORING DEVICES BY PULSE OXIMETERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 35 US VITAL SIGNS MONITORING DEVICES BY PULSE OXIMETERS 2022–2028 ($ BILLION)

EXHIBIT 36 US VITAL SIGNS MONITORING DEVICES MARKET BY BLOOD PRESSURE MONITORS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 37 US VITAL SIGNS MONITORING DEVICES MARKET BY BLOOD PRESSURE MONITORS 2022–2028 ($ BILLION)

EXHIBIT 38 US VITAL SIGNS MONITORING DEVICES MARKET BY BODY TEMPERATURE MONITORS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 39 US VITAL SIGNS MONITORING DEVICES MARKET BY BODY TEMPERATURE MONITORS 2022–2028 ($ BILLION)

EXHIBIT 40 US INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 41 US INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 42 INCREMENTAL GROWTH BY PATIENT GROUP 2022 & 2028

EXHIBIT 43 US VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 44 US VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: ABSOLUTE GROWTH (%)

EXHIBIT 45 US GERIATRIC VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 46 US GERIATRIC VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 47 US ADULT VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 48 US ADULT VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 49 US PEDIATRIC VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 50 US PEDIATRIC VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 51 INCREMENTAL GROWTH BY APPLICATION 2022 & 2028

EXHIBIT 52 US VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 53 US VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: ABSOLUTE GROWTH (%)

EXHIBIT 54 US CHRONIC CARE VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 55 PREVALENCE OF CHRONIC CONDITIONS AND THEIR EXPONENTIAL IMPACT ON HEALTHCARE COSTS IN US

EXHIBIT 56 US CHRONIC CARE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 57 CHRONIC DISEASE MANAGEMENT MARKET SHARE: US & REST OF WORLD

EXHIBIT 58 US ACUTE CARE VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 59 US ACUTE CARE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 60 INCREMENTAL GROWTH BY END-USER 2022 & 2028

EXHIBIT 61 US VITAL SIGNS MONITORING DEVICES MARKET BY END-USER: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 62 US VITAL SIGNS MONITORING DEVICES MARKET BY END-USER: ABSOLUTE GROWTH (%)

EXHIBIT 63 AUTOMATED VIRTUAL CARE

EXHIBIT 64 US HOSPITALS VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 65 US HOSPITALS VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 66 US AMBULATORY CARE SETTINGS VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 67 US AMBULATORY CARE SETTINGS VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 68 TYPES OF HOMECARE

EXHIBIT 69 US HOME CARE SETTINGS & INDIVIDUALS VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 70 US HOME CARE SETTINGS & INDIVIDUALS VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 71 US OTHER END-USER VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 72 US OTHERS END-USER VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

EXHIBIT 73 VITAL SIGNS MONITORING DEVICES MARKET PLAYERS PRESENT IN THE US

EXHIBIT 74 VENDORS OFFERING COMMERCIAL VITAL SIGNS MONITORS: MARKET DOMINANCE ANALYSIS

EXHIBIT 75 VENDORS OFFERING COMMERCIAL VITAL SIGNS MONITORING DEVICES: CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 76 BAXTER: TOTAL REVENUE 2019–2021 ($ BILLION)

EXHIBIT 77 BAXTER: R&D EXPENDITURE 2019-2021 ($ BILLION)

EXHIBIT 78 GE HEALTHCARE: TOTAL REVENUE 2019-2021 ($ BILLION)

EXHIBIT 79 GE HEALTHCARE: REVENUE BY BUSINESS SEGMENT 2019-2021 ($ BILLION)

EXHIBIT 80 GE HEALTHCARE: REVENUE BY GEOGRAPHY 2021 ($ BILLION)

EXHIBIT 81 ICU MEDICAL: REVENUE 2019–2021 ($ BILLION)

EXHIBIT 82 ICU MEDICAL: R&D EXPENDITURE 2019–2021 ($ MILLION)

EXHIBIT 83 ICU MEDICAL: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)

EXHIBIT 84 ICU MEDICAL: REVENUE BY GEOGRAPHIC REGION 2020–2021 ($ MILLION)

EXHIBIT 85 KONINKLIJKE PHILIPS: TOTAL REVENUE 2019-2021 ($ BILLION)

EXHIBIT 86 KONINKLIJKE PHILIPS: R&D EXPENDITURE 2019-2021 ($ BILLION)

EXHIBIT 87 KONINKLIJKE PHILIPS: REVENUE BY BUSINESS SEGMENT 2019–2021 ($ BILLION)

EXHIBIT 88 KONINKLIJKE PHILIPS: REVENUE BY GEOGRAPHIC REGION 2020–2021 ($ BILLION)

EXHIBIT 89 MASIMO: TOTAL REVENUE 2019–2021 ($ BILLION)

EXHIBIT 90 MASIMO: R&D EXPENDITURE 2020–2021 ($ MILLION)

EXHIBIT 91 MASIMO: REVENUE BY GEOGRAPHIC REGION 2021 ($ MILLION)

EXHIBIT 92 MEDTRONIC: REVENUE 2019–2021 ($ BILLION)

EXHIBIT 93 MEDTRONIC: R&D EXPENDITURE 2019–2021 ($ BILLION)

EXHIBIT 94 MEDTRONIC: REVENUE BY BUSINESS SEGMENT 2019–2021 ($ BILLION)

EXHIBIT 95 MEDTRONIC: REVENUE BY GEOGRAPHY 2021 ($ BILLION)

EXHIBIT 96 NIHON KOHDEN: REVENUE 2019–2021 ($ BILLION)

EXHIBIT 97 OSI SYSTEMS: REVENUE 2019–2021 ($ MILLION)

 

 

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2016−2022

TABLE 3 CLASSIFICATION OF WEARABLE TECHNOLOGY

TABLE 4 EXAMPLES OF WEARABLE DEVICES FOR VITAL SIGNS MONITORING

TABLE 5 CHANGE IN HOSPITAL STAY COST IN US 2010–2020

TABLE 6 DEVELOPMENT IN VITAL SIGNS PATIENT MONITORING DEVICES

TABLE 7 EXAMPLES OF PULSE OXIMETERS OFFERED BY LEADING MANUFACTURERS

TABLE 8 KEY CLUSTERS OF CHRONIC CONDITIONS

TABLE 9 EXAMPLES OF VITAL SIGNS MONITORS USED IN HOSPITALS

TABLE 10 FAST FACTS ON US HOSPITALS

TABLE 11 HUNDRED LARGEST HOSPITALS IN US BY BEDS

TABLE 12 LIST OF RECENT PRODUCT APPROVALS/LAUNCHES

TABLE 13 A&D COMPANY: MAJOR PRODUCT OFFERINGS

TABLE 14 BAXTER: MAJOR PRODUCT OFFERINGS

TABLE 15 CONTEC MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 16 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 17 ICU MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 18 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS

TABLE 19 MASIMO: MAJOR PRODUCT OFFERINGS

TABLE 20 MEDTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 21 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS

TABLE 22 NONIN: MAJOR PRODUCT OFFERINGS

TABLE 23 OMRON: MAJOR PRODUCT OFFERINGS

TABLE 24 OSI SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 25 100-PLUS: MAJOR PRODUCT OFFERINGS

TABLE 26 ADVANCED INSTRUMENTATIONS: MAJOR PRODUCT OFFERINGS

TABLE 27 AMERICAN DIAGNOSTIC: MAJOR PRODUCT OFFERINGS

TABLE 28 BITTIUM: MAJOR PRODUCT OFFERINGS

TABLE 29 CARDINAL HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 30 COMPASS HEALTH BRANDS: MAJOR PRODUCT OFFERINGS

TABLE 31 DRÄGERWERK AG & CO.: MAJOR PRODUCT OFFERINGS

TABLE 32 EDAN INSTRUMENTS: MAJOR PRODUCT OFFERINGS

TABLE 33 FUKUDA DENSHI: MAJOR PRODUCT OFFERINGS

TABLE 34 HALMA: MAJOR PRODUCT OFFERINGS

TABLE 35 INFINIUM MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 36 MENNEN MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 37 MICROLIFE: MAJOR PRODUCT OFFERINGS

TABLE 38 NURECA: MAJOR PRODUCT OFFERINGS

TABLE 39 OXITONE: MAJOR PRODUCT OFFERINGS

TABLE 40 QARDIO: MAJOR PRODUCT OFFERINGS

TABLE 41 ROSSMAX INTERNATIONAL: MAJOR PRODUCT OFFERINGS

TABLE 42 SOLARIS MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 43 SUNSET HEALTHCARE SOLUTIONS: MAJOR PRODUCT OFFERINGS

TABLE 44 VIATOM TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 45 VITALCONNECT: MAJOR PRODUCT OFFERINGS

TABLE 46 VIVALNK: MAJOR PRODUCT OFFERINGS

TABLE 47 VYAIRE MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 48 US VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 ($ BILLION)

TABLE 49 US VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)

TABLE 50 US VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)

TABLE 51 US VITAL SIGNS MONITORING DEVICES MARKET 2022−2028 (%)

TABLE 52 US VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)

TABLE 53 US VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 (%)

TABLE 54 US VITAL SIGNS MONITORING DEVICES MARKET BY END-USER 2022–2028 ($ BILLION)

TABLE 55 US VITAL SIGNS MONITORING DEVICES MARKET BY END-USER 2022–2028 (%)

Select a license type that suits your business needs

single-user Single User Licence
$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date